Allan Jordan strongly believes that while big data is important and can change pharma, it should not just be gathered without reason. There needs to be a purpose, and purpose is the main thing driving his latest project.
The project in question is focused on exploiting genome sequencing efforts to discover new targets for cancer treatment. A huge opportunity for positive change. Download the Case Study to find out more.
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.